CHAIR
Julie R. Brahmer, MD, MSc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
|
CHAIR
Marc S. Ernstoff, MD
National Cancer Institute
|
Members
Hamzah Abu-Sbeih, MD — University of Missouri-Kansas City
Paolo Antonio Ascierto, MD — Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale'
Jill Brufsky, PharmaD (Patient) — University of Pittsburgh Medical Center
Laura C. Cappelli, MD, MHS, MS — Johns Hopkins University
Frank B. Cortazar, MD — Massachusetts General Hospital
David E. Gerber, MD — Harold C. Simmons Comprehensive Cancer Center
Lamya Hamad, RPh, MPH — Roswell Park Comprehensive Cancer Center
Eric Hansen, MD — Roswell Park Comprehensive Cancer Center
Douglas B. Johnson, MD, MSCI — Vanderbilt-Ingram Cancer Center
Mario E. Lacouture, MD — Memorial Sloan Kettering Cancer Institute
Gregory A. Masters, MD, FACP, FASCO — Helen F. Graham Cancer Center
Jarushka Naidoo, MBBCH MHS — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Beaumont Hospital, The Royal College of Surgeons of Ireland.
Michele Nanni, PA — Roswell Park Comprehensive Cancer Center
*Miguel-Angel Perales, MD — Memorial Sloan Kettering Cancer Center
Igor Puzanov, MD, MSCI, FACP — Roswell Park Comprehensive Cancer Center
Bianca D. Santomasso, MD, PhD — Memorial Sloan Kettering Cancer Center
Satish P. Shanbhag, MBBS, MPH — Johns Hopkins University
Rajeev Sharma, MBBS, MD, FACE — Roswell Park Comprehensive Cancer Center
Dimitra Skondra, MD, PhD — The University of Chicago Medical Center
Jeffery A. Sosman, MD — Northwestern University
Michelle Turner, NP — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
*SITC is a proponent for collaboration and harmonization of efforts between like-minded organizations whenever possible. SITC wishes to thank the American Society of Transplantation and Cellular Therapy (ASTCT) for providing a representative to serve on SITC’s Immune Checkpoint Inhibitor-related Adverse Events Expert Panel to aid in the development of this clinical practice guideline.